Mosessian, S., Jensen, J. D., & Enke, A. S. (2023). Current State of Clinical Trials and Regulatory Approvals with Fibroblast Activation Protein Targeting Interventions. PET clinics, 18(3), 429. https://doi.org/10.1016/j.cpet.2023.02.010
Chicago Style (17th ed.) CitationMosessian, Sherly, Jessica D. Jensen, and Aaron S. Enke. "Current State of Clinical Trials and Regulatory Approvals with Fibroblast Activation Protein Targeting Interventions." PET Clinics 18, no. 3 (2023): 429. https://doi.org/10.1016/j.cpet.2023.02.010.
MLA (9th ed.) CitationMosessian, Sherly, et al. "Current State of Clinical Trials and Regulatory Approvals with Fibroblast Activation Protein Targeting Interventions." PET Clinics, vol. 18, no. 3, 2023, p. 429, https://doi.org/10.1016/j.cpet.2023.02.010.